The type II latency program, with further restricted viral gene expression patterns of EBNA-1, LMP-1, and LMP-2, is predominantly found in HL, nasopharyngeal carcinoma (NPC), and gastric carcinoma (GC). The gene discussed is PSMB9; the disease is nasopharyngeal carcinoma.